These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26242828)
1. Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects. Azimi F; Mortazavi Y; Alavi S; Khalili M; Ramazani A Leuk Res; 2015 Oct; 39(10):1048-54. PubMed ID: 26242828 [TBL] [Abstract][Full Text] [Related]
2. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity. Ma X; Zheng J; Jin M; Li W; Gao C; Zhang D; Chen Y; Li X; Xie J Int J Clin Exp Pathol; 2014; 7(7):4552-6. PubMed ID: 25120852 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine. Wan Rosalina WR; Teh LK; Mohamad N; Nasir A; Yusoff R; Baba AA; Salleh MZ J Clin Pharm Ther; 2012 Apr; 37(2):237-41. PubMed ID: 21545474 [TBL] [Abstract][Full Text] [Related]
4. Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population. Shipkova M; Lorenz K; Oellerich M; Wieland E; von Ahsen N Clin Chem; 2006 Feb; 52(2):240-7. PubMed ID: 16384889 [TBL] [Abstract][Full Text] [Related]
5. Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6. Atanasova S; Shipkova M; Svinarov D; Mladenova A; Genova M; Wieland E; Oellerich M; von Ahsen N Ther Drug Monit; 2007 Feb; 29(1):6-10. PubMed ID: 17304144 [TBL] [Abstract][Full Text] [Related]
6. Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia. Dorababu P; Nagesh N; Linga VG; Gundeti S; Kutala VK; Reddanna P; Digumarti R Eur J Clin Pharmacol; 2012 Apr; 68(4):379-87. PubMed ID: 22009189 [TBL] [Abstract][Full Text] [Related]
7. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants? Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126 [TBL] [Abstract][Full Text] [Related]
8. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Sumi S; Marinaki AM; Arenas M; Fairbanks L; Shobowale-Bakre M; Rees DC; Thein SL; Ansari A; Sanderson J; De Abreu RA; Simmonds HA; Duley JA Hum Genet; 2002 Oct; 111(4-5):360-7. PubMed ID: 12384777 [TBL] [Abstract][Full Text] [Related]
9. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia. Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813 [TBL] [Abstract][Full Text] [Related]
10. Fan POL; Leung KT; Chan KYY; Leung AWK; Lam GKS; Chow TTW; Cheng FWT; Yuen LYP; Moriyama T; Yang JJ; Li CK Pediatr Hematol Oncol; 2022 Apr; 39(3):254-266. PubMed ID: 34665987 [TBL] [Abstract][Full Text] [Related]
11. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Adam de Beaumais T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E Br J Clin Pharmacol; 2011 Apr; 71(4):575-84. PubMed ID: 21395650 [TBL] [Abstract][Full Text] [Related]
12. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population. Maeda T; Sumi S; Ueta A; Ohkubo Y; Ito T; Marinaki AM; Kurono Y; Hasegawa S; Togari H Mol Genet Metab; 2005 Aug; 85(4):271-9. PubMed ID: 15946879 [TBL] [Abstract][Full Text] [Related]
13. Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapy. Smid A; Karas-Kuzelicki N; Milek M; Jazbec J; Mlinaric-Rascan I PLoS One; 2014; 9(10):e109551. PubMed ID: 25303517 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia. Farfan MJ; Salas C; Canales C; Silva F; Villarroel M; Kopp K; Torres JP; Santolaya ME; Morales J BMC Cancer; 2014 Apr; 14():299. PubMed ID: 24774509 [TBL] [Abstract][Full Text] [Related]
15. Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment. Kouwenberg TW; van den Bosch BJC; Bierau J; Te Loo DMWM; Coenen MJH; Hagleitner MM J Pediatr Hematol Oncol; 2020 Mar; 42(2):e94-e97. PubMed ID: 31895215 [TBL] [Abstract][Full Text] [Related]
16. The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene. Arenas M; Duley J; Sumi S; Sanderson J; Marinaki A Biochim Biophys Acta; 2007 Jan; 1772(1):96-102. PubMed ID: 17113761 [TBL] [Abstract][Full Text] [Related]
17. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects. Zamzami MA; Duley JA; Price GR; Venter DJ; Yarham JW; Taylor RW; Catley LP; Florin TH; Marinaki AM; Bowling F J Hematol Oncol; 2013 Mar; 6():24. PubMed ID: 23547827 [TBL] [Abstract][Full Text] [Related]